{"title":"使用各种放射治疗技术治疗宫颈癌的临床结果","authors":"O. Kravets, Anara A. Kurmanova, V. N. Bogatyrev","doi":"10.17816/onco568572","DOIUrl":null,"url":null,"abstract":"Background: clinical results of patients with cervical cancer (CC) who treated with different methodological approaches of radiotherapy (RT) in the transforming from conventional to conformal RT and brachytherapy (BT). Purpose: to evaluate long-term results of treatment, locoregional and distant control. Methods: 137 patients with CC IIb - IIIb in 2013-2016 were analysed: 70 (51%) - conventional gamma therapy and brachytherapy (BT) with two-dimensional planning (2D) 60Сo alone or in combination with cisplatin 40 mg/m2 two groups of n=35. The total dose (TD) for point A 75.08 0.57 Gy, point B 57.9 0.43 Gy. In 67 (49%) with conform radiotherapy following BT with three-dimensional planning (3D) 192Ir alone or in combination with cisplatin 40 mg/m2 - two groups n = 35 and 32, respectively. TD CTV-HR D90 95.0 Gy 0.67 EQD2. Results: 3 and 5-year overall survival with 3D RT versus 2D RT was 84.6 4.5% and 63.1 6.0%; 84.6 4.5% versus 56.1 6.0%, respectively (p = 0.030). It was revealed that modern technologies are important in improving overall survival with image-guided RT: 88.2 6.6% of patients are alive for 3 years versus 59.0 8.4%, respectively (p=0.027). The use of chemoradiotherapy (CRT) showed an advantage of 3-year event-free survival in groups with 2D RT - 67.9 8.4% versus 55.2 8.6% (p = 0.042) in 3D RT - no statistically significant differences. Locoregional control was higher in the 3D RT groups at 3 years follow-up: 97.0 2.9% versus 82.9 5.3%, p = 0.050. CRT allows to reduce the number of local failures in the pelvis in the follow-up period up to 6 months, regardless of the RT technologies. The number of relapses and metastases in pelvis is lower in 3D RT - 3.0 2.1% versus 2D - 15.7 4.4% (p = 0.05). The frequency of metastases did not show statistically significant differences: 2D RT - 5.7 2.8% versus 3D RT - 9.0 3.5% (p 0.05). Conclusion: the study proves the improvement of local control in the treatment of cervical cancer in cases of conformal RT and 3D BT.","PeriodicalId":509207,"journal":{"name":"Russian Journal of Oncology","volume":"10 6","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-12-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"CLINICAL RESULTS OF CERVIX CANCER USING VARIOUS TECHNOLOGIES IN RADIATION THERAPY\",\"authors\":\"O. Kravets, Anara A. Kurmanova, V. N. Bogatyrev\",\"doi\":\"10.17816/onco568572\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Background: clinical results of patients with cervical cancer (CC) who treated with different methodological approaches of radiotherapy (RT) in the transforming from conventional to conformal RT and brachytherapy (BT). Purpose: to evaluate long-term results of treatment, locoregional and distant control. Methods: 137 patients with CC IIb - IIIb in 2013-2016 were analysed: 70 (51%) - conventional gamma therapy and brachytherapy (BT) with two-dimensional planning (2D) 60Сo alone or in combination with cisplatin 40 mg/m2 two groups of n=35. The total dose (TD) for point A 75.08 0.57 Gy, point B 57.9 0.43 Gy. In 67 (49%) with conform radiotherapy following BT with three-dimensional planning (3D) 192Ir alone or in combination with cisplatin 40 mg/m2 - two groups n = 35 and 32, respectively. TD CTV-HR D90 95.0 Gy 0.67 EQD2. Results: 3 and 5-year overall survival with 3D RT versus 2D RT was 84.6 4.5% and 63.1 6.0%; 84.6 4.5% versus 56.1 6.0%, respectively (p = 0.030). It was revealed that modern technologies are important in improving overall survival with image-guided RT: 88.2 6.6% of patients are alive for 3 years versus 59.0 8.4%, respectively (p=0.027). The use of chemoradiotherapy (CRT) showed an advantage of 3-year event-free survival in groups with 2D RT - 67.9 8.4% versus 55.2 8.6% (p = 0.042) in 3D RT - no statistically significant differences. Locoregional control was higher in the 3D RT groups at 3 years follow-up: 97.0 2.9% versus 82.9 5.3%, p = 0.050. CRT allows to reduce the number of local failures in the pelvis in the follow-up period up to 6 months, regardless of the RT technologies. The number of relapses and metastases in pelvis is lower in 3D RT - 3.0 2.1% versus 2D - 15.7 4.4% (p = 0.05). The frequency of metastases did not show statistically significant differences: 2D RT - 5.7 2.8% versus 3D RT - 9.0 3.5% (p 0.05). Conclusion: the study proves the improvement of local control in the treatment of cervical cancer in cases of conformal RT and 3D BT.\",\"PeriodicalId\":509207,\"journal\":{\"name\":\"Russian Journal of Oncology\",\"volume\":\"10 6\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-12-25\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Russian Journal of Oncology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.17816/onco568572\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Russian Journal of Oncology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.17816/onco568572","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
CLINICAL RESULTS OF CERVIX CANCER USING VARIOUS TECHNOLOGIES IN RADIATION THERAPY
Background: clinical results of patients with cervical cancer (CC) who treated with different methodological approaches of radiotherapy (RT) in the transforming from conventional to conformal RT and brachytherapy (BT). Purpose: to evaluate long-term results of treatment, locoregional and distant control. Methods: 137 patients with CC IIb - IIIb in 2013-2016 were analysed: 70 (51%) - conventional gamma therapy and brachytherapy (BT) with two-dimensional planning (2D) 60Сo alone or in combination with cisplatin 40 mg/m2 two groups of n=35. The total dose (TD) for point A 75.08 0.57 Gy, point B 57.9 0.43 Gy. In 67 (49%) with conform radiotherapy following BT with three-dimensional planning (3D) 192Ir alone or in combination with cisplatin 40 mg/m2 - two groups n = 35 and 32, respectively. TD CTV-HR D90 95.0 Gy 0.67 EQD2. Results: 3 and 5-year overall survival with 3D RT versus 2D RT was 84.6 4.5% and 63.1 6.0%; 84.6 4.5% versus 56.1 6.0%, respectively (p = 0.030). It was revealed that modern technologies are important in improving overall survival with image-guided RT: 88.2 6.6% of patients are alive for 3 years versus 59.0 8.4%, respectively (p=0.027). The use of chemoradiotherapy (CRT) showed an advantage of 3-year event-free survival in groups with 2D RT - 67.9 8.4% versus 55.2 8.6% (p = 0.042) in 3D RT - no statistically significant differences. Locoregional control was higher in the 3D RT groups at 3 years follow-up: 97.0 2.9% versus 82.9 5.3%, p = 0.050. CRT allows to reduce the number of local failures in the pelvis in the follow-up period up to 6 months, regardless of the RT technologies. The number of relapses and metastases in pelvis is lower in 3D RT - 3.0 2.1% versus 2D - 15.7 4.4% (p = 0.05). The frequency of metastases did not show statistically significant differences: 2D RT - 5.7 2.8% versus 3D RT - 9.0 3.5% (p 0.05). Conclusion: the study proves the improvement of local control in the treatment of cervical cancer in cases of conformal RT and 3D BT.